AMRX
Amneal·NASDAQ
--
--(--)
--
--(--)
AMRX Filings
Filing Date
Form Description
Form Type
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2026-01-28
Form 8-K - Current report
Key Events
2026-01-28 · Key Events
Form 8-K - Current report
2026-01-13
Form 8-K - Current report
Key Events
2026-01-13 · Key Events
Form 8-K - Current report
2025-11-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-17
Form 144 - Report of proposed sale of securities
Ownership
2025-11-17 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-14
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-11-14 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-11-12
Form 144 - Report of proposed sale of securities
Ownership
2025-11-12 · Ownership
Form 144 - Report of proposed sale of securities
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-30
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2025 Earnings Call Transcript
Earnings Call
2025-10-30 · Earnings Call
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2025 Earnings Call Transcript
2025-10-30
Form 8-K - Current report
Key Events
2025-10-30 · Key Events
Form 8-K - Current report
